RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1
- PMID: 12738763
- DOI: 10.1210/me.2002-0402
RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1
Abstract
Thyroid cancers are a leading cause of death due to endocrine malignancies. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) gene rearrangements are the most frequent genetic alterations identified in papillary thyroid carcinoma. Although the oncogenic potential of RET/PTC is related to intrinsic tyrosine kinase activity, the substrates for this enzyme are yet to be identified. In this report, we show that phosphoinositide-dependent kinase 1 (PDK1), a pivotal serine/threonine kinase in growth factor-signaling pathways, is a _target of RET/PTC. RET/PTC and PDK1 colocalize in the cytoplasm. RET/PTC phosphorylates a specific tyrosine (Y9) residue located in the N-terminal region of PDK1. Y9 phosphorylation of PDK1 by RET/PTC requires an intact catalytic kinase domain. The short (iso 9) and long forms (iso 51) of the RET/PTC kinases (RET/PTC1 and RET/PTC3) induce Y9 phosphorylation of PDK1. Moreover, Y9 phosphorylation of PDK1 by RET/PTC does not require phosphatidylinositol 3-kinase or Src activity. RET/PTC-induced phosphorylation of the Y9 residue results in increased PDK1 activity, decrease of cellular p53 levels, and repression of p53-dependent transactivation. In conclusion, RET/PTC-induced tyrosine phosphorylation of PDK1 may be one of the mechanisms by which it acts as an oncogenic tyrosine kinase in thyroid carcinogenesis.
Similar articles
-
Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases.Mol Endocrinol. 2004 Nov;18(11):2672-84. doi: 10.1210/me.2004-0168. Epub 2004 Aug 5. Mol Endocrinol. 2004. PMID: 15297606
-
Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation.Mol Endocrinol. 2003 Jun;17(6):1155-66. doi: 10.1210/me.2002-0401. Epub 2003 Mar 13. Mol Endocrinol. 2003. PMID: 12637586
-
[Effect of papillary thyroid carcinoma related gene PTC1 on subcellular localization and function of ATM cell].Ai Zheng. 2004 May;23(5):487-92. Ai Zheng. 2004. PMID: 15142440 Chinese.
-
Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.Cancer. 2005 Jun 1;103(11):2261-8. doi: 10.1002/cncr.21073. Cancer. 2005. PMID: 15880523 Review.
-
RET oncogene activation in papillary thyroid carcinoma.Adv Anat Pathol. 2001 Nov;8(6):345-54. doi: 10.1097/00125480-200111000-00005. Adv Anat Pathol. 2001. PMID: 11707626 Review.
Cited by
-
Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer.Thyroid. 2010 Jul;20(7):697-706. doi: 10.1089/thy.2010.1646. Thyroid. 2010. PMID: 20578891 Free PMC article. Review.
-
Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression.J Biol Chem. 2008 Aug 29;283(35):24061-76. doi: 10.1074/jbc.M803964200. Epub 2008 Jun 16. J Biol Chem. 2008. PMID: 18559349 Free PMC article.
-
Metabolic Reprogramming in Thyroid Cancer.Endocrinol Metab (Seoul). 2024 Jun;39(3):425-444. doi: 10.3803/EnM.2023.1802. Epub 2024 Jun 10. Endocrinol Metab (Seoul). 2024. PMID: 38853437 Free PMC article. Review.
-
Emerging Role of Oxidative Stress on EGFR and OGG1-BER Cross-Regulation: Implications in Thyroid Physiopathology.Cells. 2022 Feb 26;11(5):822. doi: 10.3390/cells11050822. Cells. 2022. PMID: 35269445 Free PMC article.
-
Multiple implications of 3-phosphoinositide-dependent protein kinase 1 in human cancer.World J Biol Chem. 2010 Aug 26;1(8):239-47. doi: 10.4331/wjbc.v1.i8.239. World J Biol Chem. 2010. PMID: 21537480 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous